Grace Therapeutics, Inc. (GRCE)
Market Open
26 Oct, 06:37 PM
NASDAQ (CM) NASDAQ (CM) Primary $
1. 77
-0.16
-8.3005%
$
32.22M Market Cap
- P/E Ratio
- Div Yield
444,981 Volume
0 Eps
$ 1.93
Previous Close 
Want to track GRCE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Grace Therapeutics, Inc. (GRCE) Statistics
Valuation metrics
Market Cap 32.22M
Enterprise value 17.65M
Trailing P/E (ttm) -1.54
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) -
Price/Book (mrq) 0.69
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.69
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 107.76K
Average volume (90 days) 162.5K
Price summary
52-Week low 1.67
52-Week high 5.18
Beta -
50-Day moving average 2.08
200-Day moving average 2.38
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:6
Last split Date 10 Jul 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.43%
Return on equity -0.36%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.24
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.8
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 11.47%
Book value per share (mrq) 2.79
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
